HF
PROK icon

HRT Financial’s ProKidney PROK Stock Holding History

HRT Financial’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-118,981
Closed -$212K – 5109
2026
Q1 		$212K Buy
+118,981
New +$252K ﹤0.01% 3161
2025
Q4 		– Sell
-211,326
Closed -$511K – 3851
2025
Q3 		$511K Sell
211,326
-4,044
-2% -$10.8K ﹤0.01% 1884
2025
Q2 		$127K Buy
+215,370
New +$168K ﹤0.01% 2162
2024
Q2 		– Sell
-171,697
Closed -$281K – 2918
2024
Q1 		$281K Buy
+171,697
New +$252K ﹤0.01% 1596
2023
Q2 		– Sell
-64,507
Closed -$730K – 3101
2023
Q1 		$730K Buy
+64,507
New +$687K 0.01% 1129
2022
Q3 		– Sell
-156,274
Closed -$1.55M – 3340
2022
Q2 		$1.55M Buy
156,274
+4,985
+3% +$49.3K 0.02% 682
2022
Q1 		$1.49M Buy
151,289
+76,478
+102% +$754K 0.01% 787
2021
Q4 		$740K Hold
74,811
– – ﹤0.01% 1439
2021
Q3 		$733K Buy
74,811
+27,298
+57% +$269K ﹤0.01% 1668
2021
Q2 		$481K Buy
+47,513
New +$480K ﹤0.01% 1820

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HRT Financial's PROK Position: Q2 2026 in Review

HRT Financial sold out of ProKidney (PROK) in Q2 2026, closing a stake of 118,981 shares — an estimated $212K sold.

HRT Financial first reported a position in PROK in Q2 2021 and held it in 10 quarters. The position peaked at $1.55M in Q2 2022. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • HRT Financial reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 118,981 ProKidney shares in Q2 2026, an estimated $212K.
  • HRT Financial first reported a position in ProKidney in Q2 2021 and held it in 10 quarters.
  • HRT Financial's ProKidney position peaked at $1.55M in Q2 2022.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.